Insider Trading History of Robbins Jim B

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Robbins Jim B since 2007. The trader's CIK number is 1367881. At the time of the last reporting, Robbins Jim B was the Vice President, Fina of Viveve Medical, Inc.. (stock ticker symbol VIVE). Also see all insider trading activities at Viveve Medical, Inc..

Note that in the past Robbins Jim B also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Micrus Endovascular Corp (MEND) by Robbins Jim B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 MEND 0 $0 1,111 $14,998 3,333 $0
2008 MEND 0 $0 0 $0 3,333 $0
2007 MEND 0 $0 4,174 $100,071 6,397 $17,229

Yearly summary of insider trading at Viveve Medical, Inc. (VIVMF) by Robbins Jim B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 VIVMF 67,568 $25,000 0 $0 0 $0


Insider trading activities at 2 companies by Robbins Jim B:

1. Micrus Endovascular Corp (MEND)

2. Viveve Medical, Inc. (VIVMF)

Table 1. Insider trading of Micrus Endovascular Corp (MEND) by Robbins Jim B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-11-13 MEND Sale 1,111 13.50 14,998
2009-06-30 MEND Option Ex 3,333 .00 0
2008-06-30 MEND Option Ex 3,333 .00 0
2007-08-17 MEND Sale 4,174 23.98 100,071
2007-08-17 MEND Option Ex 3,063 5.62 17,229
2007-06-30 MEND Option Ex 3,334 .00 0

Table 2. Insider trading of Viveve Medical, Inc. (VIVMF) by Robbins Jim B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-05-12 VIVMF Buy 67,568 .37 25,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robbins Jim B (Vice President, Fina of Viveve Medical, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.